GMV 0.00% 3.9¢ g medical innovations holdings limited

Ann: Notice of Annual General Meeting, page-63

  1. 6,165 Posts.
    lightbulb Created with Sketch. 2345
    @Captain G

    Either
    Perforamnce shares tranches are HALVED in numbers,
    or
    Milestones (targets) DOUBLED to $200m to $500m MCap,
    for fair play.

    *Directors have insider knowledge abt
    1)Deals that will be coming in the pipelines, esp what/why/when/who is "$7m for production"
    2) " Imminent sales", Vsms,
    3) Nmpa clearance expected in Q3 ( or Q4, latest ), which triggers $80m MOUs
    4) Nasdaq listing in Q3

    Milestones in this instance should be set by Independent Directors (which we dont have), not Yacov (CEO) , also chief benediciary, and largest SSHolder (45% voter, albeit he will abstain from voting on his perf.shares).
    Fair play.
    Not gifting.

    I will vote against supergenerous perf.shares to Ycov and directors, for such low targets/milestones, esp $100m MCap which can easily be hit by any one of
    item #2,3, or 4
    very shortly.

    ( Retail shh votes will not beat those resolutions.
    Any other ways?)

    ps
    *Raise targets to $200m_$500m,
    or
    Haive the Perf.shares tranches*

    Pls * tell* Henry J @G13 and R15, if you contact him
    Thx.

    Last edited by Glyco: 16/06/20
 
watchlist Created with Sketch. Add GMV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.